Altimmune to Report Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023

Rhea-AI Summary

Altimmune, Inc. will report its third quarter 2023 financial results on November 7, 2023. The company will also provide a business update. A conference call will be hosted by Altimmune management at 8:30 am E.T. on November 7 to discuss financial results and provide a business update. The conference call will be webcast live on Altimmune's Investor Relations website. A replay will be available on the Investor Relations website for up to three months.

GAITHERSBURG, Md., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will report its third quarter 2023 financial results on Tuesday, November 7, 2023 and will provide a business update.

Altimmune management will host a conference call at 8:30 am E.T. on November 7 to discuss financial results and provide a business update. The conference call will be webcast live on Altimmune’s Investor Relations website at https://ir.altimmune.com/investors.

Participants who would like to join the call may register here to receive the dial-in numbers and unique PIN to access the call. Shortly after the call, a replay will be available on the Investor Relations website for up to three months.

About Altimmune
Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation therapeutics for the treatment of obesity and liver diseases. The Company’s lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell™, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Investor Contact:
Richard Eisenstadt
Chief Financial Officer
Phone: 240-654-1450
reisenstadt@altimmune.com

Media Contact:
Danielle Cantey
Evoke Canale
Phone: 619-826-4657
danielle.cantey@evokegroup.com

FAQ

When will Altimmune report its third quarter 2023 financial results?

Altimmune will report its third quarter 2023 financial results on November 7, 2023.

Will Altimmune provide a business update along with the financial results?

Yes, Altimmune will provide a business update along with the financial results.

What time will the conference call be hosted on November 7?

The conference call will be hosted at 8:30 am E.T. on November 7.

Where can I access the live webcast of the conference call?

The live webcast of the conference call can be accessed on Altimmune's Investor Relations website at https://ir.altimmune.com/investors.

Will there be a replay of the conference call available?

Yes, a replay of the conference call will be available on Altimmune's Investor Relations website for up to three months.